1. Market Research
  2. > Pharmaceutical Market Trends
North America Clinical Nutrition Market - Growth, Trends, and Forecast (2019 - 2024)

North America Clinical Nutrition Market - Growth, Trends, and Forecast (2019 - 2024)

  • April 2019
  • 92 pages
  • ID: 5778446
  • Format: PDF
  • By Mordor Intelligence LLP

Summary

Table of Contents

Search Inside

Market Overview
- The North American clinical nutrition market is well-established, owing to multiple factors contributing to the growth. Some of the primary factors include a large geriatric population base, the growing burden of chronic diseases, and increased awareness in the society regarding clinical nutrition.
- Recent years have observed high focus by the companies and hospitals, toward health and wellness, aging, and disease prevention. For a number of chronic diseases, such as coronary artery disease, ischemic stroke, diabetes, diabetes, and few cancer indications, preventive medical nutrition is effective and steadily being adopted by hospitals and clinics in North America.
- Moreover, healthcare expenditure continues to grow faster than economic growth in most countries. The presence of equitable, responsive, and efficient health systems across North American countries has also contributed to the maximum share of GDP, for healthcare expenditure. Such factors drive the demand for clinical nutrition in North America.

Scope of the Report
The report on North America clinical nutrition market is segmented by route of administration, application, and end user. The route of administration includes oral and enteral, and parenteral. By application, the market report includes nutritional support in malnutrition, metabolic disorders, gastrointestinal diseases, neurological disease, cancers, and other indications. The end users are segmented into pediatric and adult sub-segments.

Clinical nutrition products help to keep the patient healthy and aid to improving the metabolic system of the body by providing adequate supplements, such as minerals, vitamins, and others. Additionally, the high birth rate and a higher number of premature births also demand advanced clinical nutrition.

Key Market Trends
Oral and Enteral Route of Administration is Estimated to Hold the Largest Share in the North America Clinical Nutrition Market

In terms of route of administration of clinical nutrition to the patients, oral and enteral routes are mostly preferred for a large number of diseases for a significant period of disease treatment. As long as the patients can consume food orally, their stomach and intestine functionalities are not affected, the oral route is the preferred route of administration for clinical nutrition. There are several types of formulations for enteral nutrition, which are preferred based on the complexity of diseases by physicians and doctors, such as liquid solution, soluble tablets, dispersible tablets, and capsules, among others. In several cases, patients suffering from the trauma of mouth and throat, and few cancers of the GI tract, like mouth cancer, throat cancer, etc., the preferred route of administration is enteral. However, the initial cost of set-up is high for such facilities, which limit the growth of this segment to some extent. As several well-established companies have good distribution model across the North America region, this offsets the barriers linked to this segment.

Competitive Landscape
There are several international major players, as well as domestic companies in the United States, Canada, and Mexico, which creates a good competitive scenario for companies in the North American clinical nutrition market. Some of the major companies having a good presence across the North American region include Abbott, Nestle, Baxter B Braun, and Danone Nutricia.

Reasons to Purchase this report:
- The market estimate (ME) sheet in Excel format
- Report customization as per the client’s requirements
- 3 months of analyst support

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 150+ Million searchable statistics with tables, figures & datasets
  • More than 25,000 trusted sources
10% Off

($3850)

  • Single User License — provides access to the report by one individual.
  • Department License — allows you to share the report with up to 5 users
  • Site License — allows the report to be shared amongst all employees in a defined country
  • Corporate License — allows for complete access, globally.
Ahmad helps you find the right report:
Testimonials

The research specialist advised us on the best content for our needs and provided a great report and follow-up, thanks very much we shall look at ReportLinker in the future.

Kate Merrick

Global Marketing Manager at
Eurotherm by Schneider Electric

We were impressed with the support that ReportLinker’s research specialists’ team provided. The report we purchased was useful and provided exactly what we want.

Category Manager at
Ikea

ReportLinker gave access to reliable and useful data while avoiding dispersing resources and spending too much time on unnecessary research.

Executive Director at
PwC Advisory

The customer service was fast, responsive, and 100% professional in all my dealings (...) If we have more research needs, I'll certainly prioritize working with ReportLinker!

Scott Griffith

Vice President Marketing at
Maurice Sporting Goods

The research specialist provided prompt, helpful instructions for accessing ReportLinker's product. He also followed up to make sure everything went smoothly and to ensure an easy transition to the next stage of my research

Jessica P Huffman

Research Associate at
American Transportation Research Institute

Excellent customer service. Very responsive and fast.

Director, Corporate Strategy at
Ingredion

I reached out to ReportLinker for a detailed market study on the Air Treatment industry. The quality of the report, the research specialist’s willingness to solve my queries exceeded my expectations. I would definitely recommend ReportLinker for in-depth industry information.

Mariana Mendoza

Global Platform Senior Manager at
Whirlpool Corporation

Thanks! I like what you've provided and will certainly come back if I need to do further research works.

Bee Hin Png

CEO at
LDR Pte Ltd

The research specialist advised us on the best content for our needs and provided a great report and follow-up, thanks very much we shall look at ReportLinker in the future.

Kate Merrick

Global Marketing Manager at
Eurotherm by Schneider Electric

FAQ
  • How we can help
    • I am not sure if the report I am interested in will fulfill my needs. Can you help me?
    • Yes, of course. You can call us at +33(0) 4 37 65 17 03 or drop us an email at researchadvisor@reportlinker.com to let us know more about your requirements.
    • We buy reports often - can ReportLinker get me any benefits?
    • Yes. Set up a call with a Senior Research Advisor to learn more - researchadvisor@reportlinker.com or +33(0) 4 37 65 17 03.
    • I have had negative experiences with market research reports before. How can you avoid this from happening again?
    • We advise all clients to read the TOC and Summary and list your questions so that we can get more insight for you before you make any purchase decision. A research advisor will accompany you so that you can compare samples and reports from different sources, and choose the study that is right for you.

  • Report Delivery
    • How and when I will receive my Report?
    • Most reports are delivered right away in a pdf format, while others are accessed via a secure link and access codes. Do note that sometimes reports are sent within a 12 hour period, depending on the time zones. However, you can contact us to escalate this. Should you need a hard copy, you can check if this option is offered for the particular report, and pay the related fees.
  • Payment conditions
    • What payment methods do you accept?
      1. Credit card : VISA, American Express, Mastercard, or
      2. You can download an invoice to pay by wire transfer, check, or via a Purchase Order from your company, or
      3. You can pay via a Check made out in US Dollars, Euros, or British Pounds for the full amount made payable to ReportLinker
    • What are ReportLinker’s Payment Terms?
    • All payments must normally be submitted within 30 days. However, you can let us know if you need extended time.
    • Are Taxes and duties included?
    • All companies based in France must pay a 20% tax per report. The same applies to all individuals based in the EU. All EU companies must supply their VAT number when purchasing to avoid this charge.
    • I’m not satisfied. Can I be refunded?
    • No. Once your order has been processed and the publisher has received a notification to send you the report, we cannot issue any refund or cancel any order. As these are not ‘traditional’ products that can be returned, reports that are dispatched are considered to be ‘consumed’.
  • User license
    • The license that you should acquire depends on the number of persons that need to access the report. This can range from Single User (only one person will have the right to read or access the report), or Department License (up to 5 persons), to Site License (a group of persons based in the same company location), or Corporate License (the entire company personnel based worldwide). However, as publishers have different terms and conditions, we can look into this for you.
Purchase Reports From Reputable Market Research Publishers
Iron Deficiency Anemia - Pipeline Review, H2 2019

Iron Deficiency Anemia - Pipeline Review, H2 2019

  • $ 2000
  • September 2019

Iron Deficiency Anemia - Pipeline Review, H2 2019SummaryThe latest Pharmaceutical and Healthcare disease pipeline guide Iron Deficiency Anemia - Pipeline Review, H2 2019, provides an overview of the Iron ...

Amyloidosis - Pipeline Review, H2 2019

Amyloidosis - Pipeline Review, H2 2019

  • $ 2000
  • November 2019

Amyloidosis - Pipeline Review, H2 2019SummaryPharmaceutical and Healthcare disease pipeline guide Amyloidosis - Pipeline Review, H2 2019, provides an overview of the Amyloidosis (Metabolic Disorders) pipeline ...

Secondary Hyperparathyroidism - Pipeline Review, H2 2019

Secondary Hyperparathyroidism - Pipeline Review, H2 2019

  • $ 2000
  • September 2019

Secondary Hyperparathyroidism - Pipeline Review, H2 2019SummaryThe latest Pharmaceutical and Healthcare disease pipeline guide Secondary Hyperparathyroidism - Pipeline Review, H2 2019, provides an overview ...


ref:plp2019

Reportlinker.com © Copyright 2019. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.

Make sure you don’t miss any news and follow us on